PLoS ONE (Jan 2016)

Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.

  • Julien Boudarham,
  • Sophie Hameau,
  • Raphael Zory,
  • Alexandre Hardy,
  • Djamel Bensmail,
  • Nicolas Roche

DOI
https://doi.org/10.1371/journal.pone.0158267
Journal volume & issue
Vol. 11, no. 6
p. e0158267

Abstract

Read online

BACKGROUND:Coactivation of agonist and antagonist lower limb muscles during gait stiffens joints and ensures stability. In patients with multiple sclerosis, coactivation of lower limb muscles might be a compensatory mechanism to cope with impairments of balance and gait. OBJECTIVE:The aim of this study was to assess coactivation of agonist and antagonist muscles at the knee and ankle joints during gait in patients with multiple sclerosis, and to evaluate the relationship between muscle coactivation and disability, gait performance, dynamic ankle strength measured during gait, and postural stability. METHODS:The magnitude and duration of coactivation of agonist-antagonist muscle pairs at the knee and ankle were determined for both lower limbs (more and less-affected) in 14 patients with multiple sclerosis and 11 healthy subjects walking at a spontaneous speed, using 3D-gait analysis. RESULTS:In the patient group, coactivation was increased in the knee muscles during single support (proximal strategy) and in the ankle muscles during double support (distal strategy). The magnitude of coactivation was highest in the patients with the slowest gait, the greatest motor impairment and the most instability. CONCLUSION:Increased muscle coactivation is likely a compensatory mechanism to limit the number of degrees of freedom during gait in patients with multiple sclerosis, particularly when postural stability is impaired.